ESCMID eLibrary

Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. OS0837

   Global transcriptional analyses of Mycobacterium tuberculosis using old and new drugs

   An Van den Bossche, Brussels, Belgium

   An Van den Bossche, Pieter-Jan Ceyssens, Roby Bhattacharyya, Deborah Hung, Vanessa Mathys

   25 April 2017

   Session: Treating tuberculosis in the era of drug resistance

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Bacterial Infection & Disease

2. OS0906

   Chronic Q fever-related complications and mortality: data from a nationwide cohort

   Sonja Evelyn Van Roeden, Utrecht, The Netherlands

   Sonja Evelyn Van Roeden, Peter Wever, Linda Kampschreur, Wim Van der Hoek, Andy I.M. Hoepelman, Chantal Bleeker-Rovers, Jan Jelrik Oosterheert

   25 April 2017

   Session: Zoonosis update

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Bacterial Infection & Disease

3. OS0842

   Pharmacokinetics of rifampicin in adults with pulmonary tuberculosis and healthy volunteers; a meta-analysis

   Katharine Elizabeth Stott, Liverpool, United Kingdom

   Katharine Elizabeth Stott, Henry Pertinez, Gerry Davies

   25 April 2017

   Session: Treating tuberculosis in the era of drug resistance

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Bacterial Infection & Disease

4. OS0989

   Do high-risk patients with acute lower respiratory tract infection benefit from treatment with amoxicillin?

   Robin Bruyndonckx, Antwerp, Belgium

   Robin Bruyndonckx, Beth Stuart, Niel Hens, Greet Ieven, Theo Verheij, Christopher Butler, Paul S. Little, Herman Goossens, Samuel Coenen

   25 April 2017

   Session: Changing landscape of community-acquired respiratory infections and treatment options

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Bacterial Infection & Disease

5. OS0843

   Evaluation of high-dose rifapentine plus clofazimine in the first-line regimen for tuberculosis in the mouse model of chemotherapy

   Vikram Saini, Baltimore, United States

   Vikram Saini, Nicole Ammerman, Sanjay Jain, Eric Nuermberger, Jacques Grosset

   25 April 2017

   Session: Treating tuberculosis in the era of drug resistance

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Bacterial Infection & Disease

6. OS0995

   Distribution of Streptococcus pneumoniae serotypes recovered from adults >= 50 years of age in select European countries over a seven-year interval (2009-2015)

   Rodrigo E. Mendes, North Liberty, United States

   Rodrigo E. Mendes, Heather Sings, Leah N. Woosley, Mariana Castanheira, Robert Flamm, Raul Isturiz

   25 April 2017

   Session: Changing landscape of community-acquired respiratory infections and treatment options

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Bacterial Infection & Disease

7. OS0904

   Molecular risk assessment of Campylobacter jejuni recovered from human and broiler cacrcasses

   Mohamed Elhadidy, Brussels, Belgium

   Alexandra Duarte, Katelijne Dierick, Nadine Botteldoorn

   25 April 2017

   Session: Zoonosis update

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Bacterial Infection & Disease

8. OS0988

   Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteraemic pneumococccal pneumonia

   Catia Cilloniz Campos, Barcelona, Spain

   Catia Cilloniz Campos, Celia Cardozo, Adrian Ceccato, Cristina De la Calle, Albert Gabarrus, Carolina Garcia Vidal, Manel Almela, Alex Soriano, Adriana Salazar, Jose Antonio Martinez Martinez, Francesc Marco Reverte, Antonio Torres

   25 April 2017

   Session: Changing landscape of community-acquired respiratory infections and treatment options

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Bacterial Infection & Disease

9. OS0992

   Optimized combination therapy: the future to eradicate hypermutable bacteria

   Vanessa Rees, Parkville, Australia

   Vanessa Rees, Jürgen Bulitta, Antonio Oliver, Anton Peleg, Roger L. Nation, Cornelia Landersdorfer

   25 April 2017

   Session: Changing landscape of community-acquired respiratory infections and treatment options

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Bacterial Infection & Disease

10. OS0993

    Adverse events associated with fluoroquinolone and macrolide therapy in adult outpatients treated for community-acquired pneumonia

    Antonio Lepore, Mishawaka, United States

    Thomas Lodise, Donna Mildvan, Antonio Lepore, Peter Classi, Glenn Tillotson

    25 April 2017

    Session: Changing landscape of community-acquired respiratory infections and treatment options

    Relevance:

     

    100%

     

    

    Event: ECCMID 2017
    Vienna, Austria
    Oral presentation

    Bacterial Infection & Disease